Muhammad Akbar Ramadhan Munandar, Hendra Priatna Munandar, and Liana Herlina. 2026. “Cost-Effectiveness of Pembrolizumab As First-Line Treatment for PD-L1 Positive NSCLC: A Systematic Review”. The International Journal of Medical Science and Health Research 23 (2): 64-130. https://doi.org/10.70070/h3zdy035.